Accelerate Diagnostics Inc reports results for the quarter ended in December - Earnings Summary

Accelerate Diagnostics

29/03/2023 22:02

* Accelerate Diagnostics Inc  AXDX.OQ  reported a quarterly
adjusted loss of 14 cents​​ per share for the quarter ended in
December. The mean expectation of two analysts for the quarter
was for a loss of 15 cents per share.
    * Revenue fell 11.1% to $2.97 million from a year ago;
analysts
expected $2.87 million. 
    * Accelerate Diagnostics Inc's reported EPS for the quarter
was a
loss of 14 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Accelerate Diagnostics Inc shares had fallen by 28.4% this
quarter.
    * The company reported a quarterly loss of $14.8 million.
    * Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $2.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 29 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.15          -0.14          Beat
 Sep. 30 2022      -0.19          -0.18          Beat
 Jun. 30 2022      -0.28          -0.23          Beat
 Mar. 31 2022      -0.30          -0.21          Beat